Your browser doesn't support javascript.
loading
Antibodies to SARS-CoV-2 and risk of past or future sick leave.
Dillner, Joakim; Elfström, K Miriam; Blomqvist, Jonas; Eklund, Carina; Lagheden, Camilla; Nordqvist-Kleppe, Sara; Hellström, Cecilia; Olofsson, Jennie; Andersson, Eni; Jernbom Falk, August; Bergström, Sofia; Hultin, Emilie; Pin, Elisa; Månberg, Anna; Nilsson, Peter; Hedhammar, My; Hober, Sophia; Mattsson, Johan; Mühr, Laila Sara Arroyo; Conneryd Lundgren, Kalle.
Afiliación
  • Dillner J; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden. Joakim.Dillner@sll.se.
  • Elfström KM; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Blomqvist J; Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Eklund C; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Lagheden C; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Nordqvist-Kleppe S; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Hellström C; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Olofsson J; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Andersson E; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Jernbom Falk A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Bergström S; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Hultin E; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Pin E; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Månberg A; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Nilsson P; Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, 171 65, Stockholm, Sweden.
  • Hedhammar M; Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Albanova, 144 21, Stockholm, Sweden.
  • Hober S; Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology, Albanova, 144 21, Stockholm, Sweden.
  • Mattsson J; Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Mühr LSA; Karolinska University Laboratory, Karolinska University Hospital, 141 86, Stockholm, Sweden.
  • Conneryd Lundgren K; Karolinska University Hospital, 141 86, Stockholm, Sweden.
Sci Rep ; 11(1): 5160, 2021 03 04.
Article en En | MEDLINE | ID: mdl-33664279

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ausencia por Enfermedad / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ausencia por Enfermedad / SARS-CoV-2 / COVID-19 / Anticuerpos Antivirales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Reino Unido